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A36-year-old womanwithpostpartum hypopituitarism(Sheehan’ssyndrome:SS)developed postpartum autoimmunethyroiditis
(PPAT). She delivered a baby by Caesarean section (620mL blood loss). At 1 month post partum, she developed thyrotoxicosis
due to painless thyroiditis (autoimmune destructive thyroiditis). She was positive for antithyroid antibodies. Postpartum and
hypoadrenalism-induced exacerbation of autoimmune thyroiditis caused the thyrotoxicosis due to autoimmune destructive
thyroiditis. ACTH was undetectable. She had ACTH deﬁciency and secondary hypoadrenalism. Hydrocortisone was started. At
6 months post partum, she was referred to us with hypothyroidism. Thyroxine was administered. She had thyrotoxicosis at 1-
2 months post partum and then hypothyroidism. She was diagnosed with PPAT. She had hypopituitarism, ACTH deﬁciency
(secondary hypoadrenalism), low prolactin with agalactia, and low LH with failure to resume regular menses. She had empty
sella on MRI. She was diagnosed with SS. Three cases with SS have been reported to develop PPAT. Postpartum immunological
rebounds and hypoadrenalism-induced immunologicalalterations (or a combinationof the two) might have been responsible for
the PPAT.
1.Introduction
Sheehan’s syndrome (SS), ﬁrst described by Sheehan in
1937 [1], is postpartum hypopituitarism caused by intra-
partum or postpartum hemorrhage. SS may cause partial
or complete hypopituitarism. It may also cause secondary
hypoadrenalism. Pregnancy and delivery have a profound
eﬀect on autoimmune thyroid diseases during gestation
and the postpartum period [2]. Postpartum transient thy-
rotoxicosis and hypothyroidism have been reported [3,
4]. They are postpartum exacerbation or development of
autoimmune thyroiditis and have been called postpartum
autoimmune thyroiditis (PPAT), postpartum thyroiditis, or
postpartum painless thyroiditis [3–8]. PPAT, postpartum
thyroiditis, or postpartum painless thyroiditis is a mem-
ber of autoimmune thyroiditis (Hashimoto’s thyroiditis)
[9]. The exacerbation and development of autoimmune
thyroiditis have also been reported after adrenalectomy in
patients with Cushing’s syndrome [10, 11]. The decrease
in cortisol after adrenalectomy exacerbates autoimmune
thyroiditis.Exacerbationofautoimmunethyroiditishasbeen
also reported after cessation of steroid therapy in a patient
with autoimmune thyroiditis and rheumatoid arthritis [12].
Three cases with SS have been reported to develop PPAT [5,
13, 14]. A case with transient thyrotoxicosis due to painless
thyroiditis (autoimmune destructive thyroiditis) following
pituitary apoplexy was also reported [15]. Pituitary apoplexy
and SS may cause secondary hypoadrenalism or a serum
cortisol decrease. This decrease in cortisol may exacerbate
autoimmune thyroid diseases. Steroid hormones decrease
after delivery. Postpartum steroid hormone decrease may
exacerbate autoimmune thyroid diseases.2 Journal of Thyroid Research
We encountered a patient with postpartum hypopitu-
itarism (Sheehan’s syndrome: SS), who developed post-
partum autoimmune thyroiditis (PPAT) (transient thyro-
toxicosis and hypothyroidism). Postpartum immunologi-
cal rebounds and hypoadrenalism-induced immunological
alterations (or a combination of the two) might have been
responsible for the development of PPAT in this patient.
2.Materialsand Methods
2.1. Hormone Assays. Serum TSH, free T3, free T4, total
T3, total T4, thyroglobulin, antithyroid peroxidase anti-
body (TPOAb), antithyroglobulin antibody (TGAb),proges-
terone, estradiol, serum prolactin, and plasma ACTH were
determined by electrochemiluminescence immunoassays
(ECLIA) (Roche Diagnostics, Tokyo, Japan). The intraassay
coeﬃcient of variation (CV) was 2.1%, 3.5%, 5.2%, 4.3%,
3.2%, 5.1%, 5.1%, 6.5%, 4.5%, 3.3%, 3.1%, and 3.6%,
respectively, and interassay CV was 3.5%, 8.4%, 9.4%, 9.4%,
8.2%, 7.8%, 9.4%, 10.6%, 9.2%, 6.4%, 6.5%, and 7.2%,
respectively. Serum TSH receptor antibody (TRAb) (TRAb
(human)) was determined by a radioreceptor assay (RRA)
(Yamasa Co., Tokyo, Japan). The intraassay CV was 7.6%,
and interassay CV was 12.4%. Serum cortisol, GH, IGF-1,
and urinary cortisol were measured by radioimmunoassay
(RIA) (TFB, Inc., Tokyo, Japan). The intraassay CV was
5.8%, 3.3%, 3.0%, and 6.8%, respectively, and interassay CV
was 8.9%, 6.5%, 6.2%, and 10.2%, respectively. LH and FSH
were measured by chemiluminescence immunoassay (CLIA)
(AbbottLab.,Tokyo,Japan).Theintraassay CVwas3.5%and
3.3%, respectively, and interassay CV was 6.5% and 7.2%,
respectively. Plasma ADH was measured by RIA (Mitsubishi
Chemical Medicine Corp., Tokyo, Japan). The intraassay CV
was 6.1%, and interassay CV was 9.5%. Hormone assays
were performed at the SRL Institute (Tokyo, Japan). Normal
reference ranges for hormone concentrations are described
in the tables, legends for ﬁgures, or elsewhere as cited.
2.2. Endocrine and Other Studies. A thyrotropin-releasing
hormone (TRH) test, using 500µgT R H ,w a sp e r f o r m e dt o
estimate TSH and prolactin secretion. The test was done in
the morning after an overnight fast. Samples for TSH and
prolactin were drawn at 0, 30, 60, 90, and 120 minutes after
intravenous TRH administration. Peak TSH and prolactin
levels occur at 30 minutes in normal subjects.
A corticotrophin-releasing hormone (CRH) test, using
100µg CRH (human CRH: Corticorelin), was performed to
estimate ACTH secretion. The test was done in the morning
afteran overnightfast.The patientwas onbedrestforatleast
40 minutes before the ﬁrst blood sample was drawn. Plasma
ACTH and serum cortisol levels were measured at 0, 30, 60,
90, and 120 minutes after the intravenous CRH injection.
PeakACTHlevelsoccurat30–60minutesinhealthysubjects,
while a lack of ACTH secretion is seen in patients with
pituitary ACTH insuﬃciency.
A gonadotropin-releasing hormone (GnRH) test, using
100µg GnRH (LH-RH), was performed to estimate LH and
FSH secretion. The test was done in the morning after
an overnight fast. Samples for LH and FSH were drawn
at 0, 30, 60, 90, and 120 minutes after the intravenous
GnRH injection. Gonadotropin deﬁciency was diagnosed by
subnormalLHandFSHr esponsestoGnRH.TRH,CRH,and
GnRH tests were performed separately.
An insulin tolerance test (ITT) was used to test growth
hormone (GH) secretion. The test was performed in the
morning after an overnight fast. Five-unit insulin was given
intravenously, and glucose and GH concentrations were
measured at −30, 0, 30, 60, 90, and 120 minutes. GH
deﬁciency was deﬁned by a peak GH response of less than
3µg/L with low concentrations of IGF-I [16].
Written informed consent was obtained from the patient
prior to publication of this paper.
3.Case Report
A36-year-oldJapanesewomanwasreferredtousat6months
post partum with easy fatigability and agalactia (Figure 1
and Table 1, 6 months). She had delivered a full-term baby
by Caesarean section (Figure 1, Delivery). Her blood-loss
was estimated to be 620mL. During the delivery, she did
not have hypotension and remained normotensive. She was
discharged without any apparent complications. However,
she begantocomplainofeasyfatigability,lassitude,agalactia,
and loss of appetite after the delivery.
She visited a doctor at 1 month post partum (Figure 1
and Table 1, 1 month). A physical examination at that
time revealed a supine blood pressure of 90/48mmHg. Her
pulse rate was 122/min and temperature was 37.2◦C. An
examination showed moist skin and ﬁnger tremors with
clear lungs and a soft abdomen. Exophthalmoses were not
observed. She had thyrotoxicosis clinically. A thyroid func-
tion study demonstrated that she had thyrotoxicosis; serum
free T3 and free T4 levels were elevated, and serum TSH
levels were undetectable (Figure 1 and Table 1,1 - 2m o n t h s ) .
She was negative for TRAb. However, she was positive for
TPOAb and TGAb. At 1 month ante partum, her TPOAb
was 3.4kIU/L and her TGAb was 52.0 kIU/L (Table 1). At 2
monthspostpartum,herTPOAbhadincreasedto42.2kIU/L
and her TGAb had increased to 138.4kIU/L. Her serum
thyroglobulin was 72µg/L (normal < 32µg/L), radioactive
iodine uptakewas0.5%/24hr(normal10–40%),and thyroid
scanning with radioiodine showed no detectable uptake.
She had thyrotoxicosis due to autoimmune destructive
thyroiditis. Her plasma ACTH was less than 0.4pmol/L, and
her serum cortsol was less than 5.5nmol/L. She therefore
had ACTH deﬁciency and secondary hypoadrenalism; 20mg
hydrocortisone (HC) was started (Figure 1,1m o n t hp o s t
partum). The thyrotoxicosis, dueto autoimmunedestructive
thyroiditis, subsided spontaneously. She became euthyroid.
At 4 months post partum, she had hypothyroidism with a
serum TSH of 6.6mIU/L (Figure 1 and Table 1,4m o n t h s ) .
At6monthspostpartum,shewasreferred touswitheasy
fatigability and agalactia (Figure 1 and Table 1,6m o n t h s ) .
On admission, she was well oriented and fully conscious.
Her height was 163cm, and her weight was 52.7kg. She was
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Figure 1: The clinical course of a patient with postpartum hypopituitarism (Sheehan’s syndrome: SS), who developed postpartum
autoimmune thyroiditis (PPAT) (transient thyrotoxicosis and hypothyroidism). A 36-year-old woman delivered a full-term baby by
Caesarean section (Delivery). At 1 month post partum, she visited a doctor with thyrotoxicosis (Toxico). She was negative for TRAb.
However, she was positive for TPOAb and TGAb. TPOAb- and TGAb-titers increased after delivery. Her serum thyroglobulin was 72µg/L
(normal< 32µg/L). Radioactive iodine uptake was 0.5%/24hr (normal10–40%).She had thyrotoxicosis (Toxico) due to painlessthyroiditis
(autoimmune destructive thyroiditis). Her ACTH was less than 0.4pmol/L, and her cortisol was less than 5.5nmol/L. She had ACTH
deﬁciency and secondary hypoadrenalism;20mghydrocortisone (HC) was started. The thyrotoxicosis subsided spontaneously.At 4 months
post partum, she developed hypothyroidism (hypothyroidism) with TSH 6.6mIU/L. At 6 months post partum, she was referred to us with
easy fatigability and agalactia. She had hypothyroidism with TSH 16.8mIU/L. She had thyrotoxicosis (Toxico) at 1-2 months post partum
and then hypothyroidism (hypothyroidism) (PPAT). At 7 months, thyroxine (T4) was started. She had hypopituitarism and empty sella on
MRI (SS). She is now taking 75µg T4 and 20mg HC daily. Normal reference ranges: TSH 0.4–4.20mIU/L, free T3 (free triiodothyronine)
3.5–6.6nmol/L,and free T4 (free thyroxine) 11.6–21.9pmol/L.
Table 1:Results ofthyroid and adrenal function tests andTPOAb and TGAb at 1 monthbefore delivery (−1m )( 1m o n t ha n t ep a r t u m )a n d
1–10 months after delivery (1–10 m) (1–10 months post partum).
Months (m)∗ −1m 1m 2m 4m 6m 7m 8m 9m 10m
Free T3 pmol/L 4.9 26.2 28.5 2.5 1.5 1.2 2.3 2.5 3.9
Free T4 pmol/L 15.4 70.8 75.9 4.3 1.4 0.9 8.7 10.9 15.4
TSH mIU/L 2.2 <0.005 <0.005 6.6 16.8 24.8 20.8 17.4 2.8
ACTH pmol/L 11.5 <0.4 <0.4∗∗ <0.4∗∗
Cortisol nmol/L 690 <5.5 <5.5∗∗ <5.5∗∗
TPOAb kIU/L 3.4 42.2 34.1 26.8
TGAb kIU/L 52.0 138.4 126.7 102.3
TRAb IU/L 0.3 0.4 0.5 0.4
Months (m)∗: −1m: 1 month before delivery (1 month ante partum) and 1–10 m: 1–10 months after delivery (1–10 months post partum). ∗∗Oral
hydrocortisone (HC)hadbeendiscontinuedfor1weekbeforethestudy.Free T3:freetriiodothyronine, freeT4:freethyroxine,TPOAb: antithyroidperoxidase
antibody, TGAb: antithyroglobulin antibody, and TRAb: TSH receptor antibody. Normal reference ranges: free T3 3.5–6.6nmol/L, free T4 11.6–21.9pmol/L,
TSH 0.4–4.20mIU/L, ACTH 1.70–12.27pmol/L, cortisol 110–505nmol/L, TPOAb < 0.3kIU/L, TGAb < 0.3kIU/L, and TRAb (TRAb (human)) < 1.0IU/L.
A patient with postpartum hypopituitarism (SS) developed postpartum autoimmune thyroiditis (PPAT). At 1 month post partum, she had thyrotoxicosis.
She was negative for TRAb. She was positive for TPOAb and TGAb. TPOAb- and TGAb-titers increased after delivery. Serum thyroglobulin was 72µg/L
(normal < 32µg/L). She had painless thyroiditis (autoimmune destructive thyroiditis). She had thyrotoxicosis due to destructive thyroiditis. ACTH was less
than 0.4pmol/L and cortisol was less than 5.5nmol/L. She had ACTH deﬁciency and secondary hypoadrenalism; HC was started. At 4 months, she had
hypothyroidism withTSH 6.6mIU/L. At 6 months, TSH was 16.8mIU/L. At7 months, thyroxine (T4) was started. She had thyrotoxicosis at 1-2 months post
partum and then hypothyroidism (PPAT).She had hypopituitarism (SS). She is now taking T4 and HC.
was 100/64mmHg. Her pulse rate was 72/min. Her skin was
not moist. She had a goiterand delayed deep tendon reﬂexes.
She had sparse axillary and pubic hairs. She had atrophy
of the breasts and agalactia. She had also failed to resume
regular menses after delivery. Systemic examination did not
indicate any other abnormalities. She had hypothyroidism
with a serum TSH of 16.8mIU/L (Figure 1 and Table 1,6
months). Figure 1 shows her clinical course. Since she had
thyrotoxicosis at 1-2 months post partum and then devel-










(b) 6 months post partum
Figure 2: Sequential magnetic resonance imaging (MRI) (T1 weighted image: T1WI) demonstrated changes of the pituitary gland. At 2
months post partum, MRI revealed a normal pituitary gland ((a1) T1WI sagittal, (a2) T1WI coronal). At 6 months post partum, MRI
revealed atrophy of the pituitary gland and empty sella ((b1) T1WI sagittal, (b2) T1WI coronal). At 6 months post partum, she had empty
sella on MRI. The arrows indicate the pituitary gland.
autoimmune thyroiditis (PPAT). At 7 months post partum,
thyroxine (T4) was started. She is now taking 75µgT 4a n d
20mg HC daily.
The patient had adrenal insuﬃciency. The laboratory
evaluation at 6 months post partum had revealed that
she had low plasma ACTH, low serum cortisol (Table 1,
6m o n t h s ,Table 2), and low urinary cortisol (Table 3(a)).
Table 3(b) demonstrates that she had no ACTH response
to CRH. She therefore had ACTH deﬁciency and secondary
hypoadrenalism.
She had agalactia. She had low serum prolactin (Tables 2
and 3(b)) and a low prolactin response to TRH (Table 3(b)).
She had failed to resume regular menses after delivery. She
had low LH (Tables 2 and 3(b)) and delayed LH and FSH
responses to GnRH (Table 3(b)).
At 6 months, she had hypothyroidism with a serum TSH
of 16.8mIU/L (Figure 1 and Table 1,6m o n t h s ,Table 2).
The elevated TSH levels indicated that she had primary
hypothyroidism. She was positive for TPOAb and TGAb. She
therefore had primary hypothyroidism due to autoimmune
thyroiditis. Her TSH levels were high, her TSH response to
TRH was delayed, and the magnitude ofthe TSH response to
TRH was low (Table 3(b)), indicating that the pituitary TSH
response to TRH might be impaired. It is possible that she
had pituitary TSH secretion failure due to SS, in addition
to primary hypothyroidism due to autoimmune thyroiditis
[17].
The GH response to ITT was blunted (Table 3(c)) and
t h eI G F - 1l e v e lw a si nt h el o w e rn o r m a lr a n g e( Table 2). The
patient therefore had partial GH deﬁciency. She did not have
diabetes insipidus (Table 3(d)).
The patient was determined to have hypopituitarism,
ACTHdeﬁciency(secondaryhypoadrenalism), lowprolactin
with agalactia, and low LH with failure to resume regular
menses. Sequential magnetic resonance imaging (MRI)
demonstrated changes in the pituitary gland. At 2 months
post partum, MRI had revealed a normal pituitary gland
(Figure 2(a)), while, at 6 months, MRI revealed atrophy of
the pituitary gland and empty sella (Figure 2(b)).
In summary, a patient with postpartum hypopituitarism
(Sheehan’s syndrome: SS) developed postpartum autoim-
mune thyroiditis (PPAT). She had hypopituitarism (ACTHJournal of Thyroid Research 5
deﬁciency, low prolactin, and low LH) and empty sella on
MRI (SS). She developed transient thyrotoxicosis at 1-2
months post partum and then subsequent hypothyroidism
(PPAT).
4.Discussion
A patient with postpartum hypopituitarism (Sheehan’s syn-
drome: SS) developed postpartum autoimmune thyroiditis
(PPAT). After delivery, she had agalactia and failure to
resume regular menses and was found to have hypopitu-
itarism and empty sella on MRI (SS). She had transient
thyrotoxicosis at 1-2 months post partum and then devel-
oped hypothyroidism (PPAT). Postpartum immunologi-
cal rebounds and hypoadrenalism-induced immunological
alterations (or a combination of the two) may have been
responsible for the development of PPAT.
SS may cause secondary hypoadrenalism. SS is charac-
terized by a wide spectrum of clinical features. In the past,
hypothyroidism in the postpartum period was considered
in the context of hypopituitarism due to SS. However,
studies over the past several decades have altered this
concept. Exacerbation or development of autoimmune thy-
roid diseases has been reported to occur among women
after uneventful delivery and has been called postpartum
autoimmune thyroiditis (PPAT), postpartum thyroiditis, or
postpartum painless thyroiditis (postpartum autoimmune
destructive thyroiditis) [3–8]. PPAT, postpartum thyroiditis,
or postpartum painless thyroiditis is a member of a group of
autoimmune thyroiditis (Hashimoto’s thyroiditis) [9].
PPAT may involve thyrotoxicosis or hypothyroidism.
The ﬁrst phase is typically thyrotoxicosis due to autoim-
mune destructive thyroiditis (painless thyroiditis). Then,
the thyroid function returns to normal. Some patients
may subsequently develophypothyroidism. Three cases with
postpartum hypopituitarism (SS) have been reported to
develop postpartum autoimmune thyroiditis (PPAT) [5, 13,
14].
The criteria for the diagnosis of SS are as follows:
(1) typical obstetric history of intrapartum or postpartum
bleeding, (2) hypotension or shock, (3) agalactia, (4) failure
to resume regular menses after delivery, (5) hypopituitarism,
and (6) empty sella on CT or MRI [18]. Our patient had
(3), (4), (5), and (6). Kaplun et al. [19]r e p o r t e dt h a t
sequential MRI demonstrates evidence of ischemic infarct in
the pituitary gland with enlargement, followed by gradual
shrinkage to pituitary atrophy. In our case, MRI revealed
atrophy of the pituitary gland and empty sella at 6 months
post partum.
SS is described as postpartum hypopituitarism due to
pituitary necrosis caused by hypotension or shock secondary
to massive bleeding during or just after delivery. The exact
pathogenesis and natural history are not understood [18].
The role of autoimmunity, including pituitary autoimmu-
nity, in the development of SS has been also suggested,
since pituitary autoantibody positivity is signiﬁcantly higher
in SS patients than controls [20, 21]. In SS, pituitary CT
or MRI reveals an empty sella, similar to our patient.
Table 2: Fasting blood hormone levels at 9:00 (6 months post
partum)∗.
Fasting hormone levels at 9:00(normal
references)
ACTH pmol/L <0.4 (1.7–12.3)
Cortisol nmol/L <5.5 (110.4–504.9)
TSH mIU/L 16.8 (0.4–4.20)
fT3 pmol/L [tT3
nmol/L] 1.54 (3.54–6.62) [0.97 (1.23–2.46)]
fT4 pmol/L [tT4
nmol/L] 1.42 (11.58–21.88) [12.9 (78.5–159.6)]
Prolactin pmol/L 104 (266–1328)
GH µg/L 1.0 (0.28–1.64)
IGF-1 µg/L 112 (73–311)
LH IU/L 0.7 (1.13–14.22)
FSH IU/L 2.9 (1.47–8.49)
Progesterone
nmol/L 98.5 (4.07–98.8)
Estradiol pmol/L 607.6 (165.2–1101.3)
∗Oral hydrocortisone (HC) had been discontinued for 1 week before
the study. fT3: free triiodothyronine, tT3: total triiodothyronine, fT4: free
thyroxine, and tT4: total thyroxine.
Komatsu et al. [22] reported that serum antipituitary
antibodies were positive in 70% of patients with empty sella
and suggested that antipituitary antibodies might be related
to the development of pituitary atrophy and the consequent
empty sella. Our patient had positive tests for TPOAb and
TGAb, indicating that she had had autoimmune thyroiditis.
Both obstetric hemorrhage and autoimmune processes may
aﬀect postpartum hypopituitarism. Immune process might
also be involved in the developmentof SS [20, 21].
Postpartum autoimmune thyroiditis (PPAT) is believed
to result from the modiﬁcations of the immune system dur-
ing pregnancy and delivery. PPAT may involve thyrotoxicosis
and/or hypothyroidism. The ﬁrst phase is typically thyro-
toxicosis dueto autoimmune destructive thyroiditis. Patients
with PPAT have positive TPOAb and/or TGAb. They may
have recurrences after each pregnancy and may eventually
develop hypothyroidism. Any woman who develops PPAT
should be carefully followed up, as she has an increased risk
of developing hypothyroidism.
Three cases with postpartum hypopituitarism (SS) have
been reported to develop postpartum autoimmune thy-
roiditis (PPAT) [5, 13, 14]( Table 4). We herein reported
another case of SS, who developed PPAT. All four cases
had positive TPOAb and/or TGAb. They initially presented
with transient thyrotoxicosis due to autoimmune destructive
thyroiditis. Three of the four patients were Japanese. The
postpartum changes of autoimmune system may be respon-
sible for the development of PPAT. SS also causes secondary
hypoadrenalism, which causes a decrease in cortisol. The
cortisol decrease can then induce immunological alterations.
Postpartum immunological rebounds and hypoadrenalism-
induced immunological alterations (or a combination of
the two) might therefore be the underlying pathogenesis6 Journal of Thyroid Research
Table 3: Endocrine studies at 6 months post partum.
(a) Urinary cortisol (studied one week after discontinuation of hydrocortisone)
(Normal references)
Urinary cortisol nmol/day <18 (30–230)
(b) CRH, TRH, and GnRH tests (CRH, TRH, and GnRH tests were done separately)
0min 30min 60min 90min 120min Response
CRH test (studied one week after discontinuation of hydrocortisone)
ACTH pmol/L <0.4 <0.4 <0.4 <0.4 <0.4 No
Cortisol nmol/L <5.5 <5.5 <5.5 <5.5 <5.5 No
TRH test
TSH mIU/L 17.4 38.1 52.9 57.1 57.7 Delayed
Prolactin pmol/L 43.5 178.3 160.9 165.2 139.1 Low
GnRH test
LH IU/L 0.5 6.6 11.1 13.1 13.7 Delayed
FSH IU/L 2.2 2.6 3.3 3.9 4.3 Delayed
Normal references for basal ACTH, cortisol, TSH, prolactin, LH, and FSH appear in Table 2.
(c) Insulin tolerance test (ITT) for GH releases
−30min 0min 30min 60min 90min 120min
GH µg/L 1.0 1.1 0.8 4.1 3.8 2.5
BG nmol/L 4.6 4.3 2.2 3.1 3.7 4.3
BG: blood glucose. Normal references for basal GH appear in Table 2.
(d) ADH (antidiuretichormone), plasma osmolality,and urine osmolalityat 9:00
(Normal references)
PlasmaADH pmol/L 0.92 (0.28–3.23)
Plasmaosmolality mmol/kg 287 (285–293)
Urine osmolalitymmol/kg 767 (300–900)
Table 4: Postpartum hypopituitarism (Sheehan’s syndrome: SS) and postpartum autoimmunethyroiditis (PPAT):a review of the literature.
Case Age, yr Nationality ATA∗ Thyroid state∗∗ Publication year Reference
Case 1 38 Japanese Positive Thyrotoxicosis 1992 [12]
“Simultaneous occurrence of postpartum hypopituitarism (Sheehan’s syndrome) and transient resolving thyrotoxicosis due to postpartum
painless thyroiditis”∗∗∗
Case 2 29 Japanese Positive Thyrotoxicosis 1997 [13]
“Painless thyroiditis developed in a patient with Sheehan’s syndrome”∗∗∗
Case 3 30 French Positive Thyrotoxicosis 2002 [4]
“Postpartum autoimmunethyroiditis in a patient presenting with Sheehan’s syndrome”∗∗∗
Case 4 36 Japanese Positive Thyrotoxicosis
“A Patient with postpartum hypopituitarism (Sheehan’s Syndrome) developed postpartum autoimmune thyroiditis (PPAT) (transient
thyrotoxicosis and hypothyroidism)”∗∗∗
ATA∗: antithyroid antibodies (antithyroid peroxidase antibody (TPOAb) and/or antithyroglobulin antibody (TGAb)). Thyroid state∗∗: the patient initially
presentedwiththyrotoxicosis. ∗∗∗:titleofthereport. Cases 1,2,and3havebeenreported previously[4,12,13],respectively.Case 4ispresentedinthispaper.
for the development of PPAT. A case of SS with Graves’
hyperthyroidism has been also reported [23].
Glucocorticoids are the main endogenous anti-inﬂam-
matory agents in vivo, interfering with every step of immune
and inﬂammatory responses [24], and are commonly used
in the treatment of autoimmune diseases. The development
of autoimmune thyroid diseases has been reported after
unilateral adrenalectomy for Cushing’s syndrome [10],
after bilateral adrenalectomy in a patient with Carney’s
complex [11] and after removal of ACTH-producing
pituitary adenoma in patients with Cushing’s disease [11].
The importance of endogenous glucocorticoids in the
control of immune conditions is also exempliﬁed by the
increased mortality associated with adrenalectomy in ratsJournal of Thyroid Research 7
with experimental allergic encephalomyelitis [25]. Transient
thyrotoxicosis was also reported to occur after cessation of
steroid therapy in a patient with autoimmune thyroiditis
and rheumatoid arthritis [12]. Another patient with hypopi-
tuitarism, following pituitary apoplexy, developed transient
thyrotoxicosis due to painless thyroiditis (autoimmune
destructive thyroiditis) [15]. Pituitary apoplexy and SS cause
ACTH deﬁciency and secondary adrenocortical insuﬃciency
(a cortisol decrease). This cortisol decrease may exacerbate
autoimmune thyroid diseases. Hypoadrenalism induces
immunological alterations, which may be associated with
the development of PPAT.
In summary, we experienced a patient with SS who
developed PPAT. Postpartum immunological rebounds and
hypoadrenalism-induced immunological alterations (or a
combination of the two) may have been responsible for the
development of PPAT.
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